Membership of the committee
Members
Senator Sue
Knowles, Chairman
|
LP, Western Australia
|
Senator Lyn
Allison, Deputy Chair
|
AD, Victoria
|
Senator George
Brandis
|
LP, Queensland
|
Senator Kay
Denman
|
ALP, Tasmania
|
Senator Chris
Evans
|
ALP, Western Australia
|
Senator Tsebin
Tchen
|
LP, Victoria
|
Report on annual reports
1.1
This report was prepared
pursuant to Standing Order 25 (21) relating to the consideration of annual
reports by Committees.[1] The annual
reports examined by the Committee are the reports of the Australian Radiation
Protection and Nuclear Safety Agency and the National Health and Medical
Research Council.
Australian
Radiation Protection and Nuclear Safety Agency 1998-99
1.2
The report was tabled in both
houses of Parliament on 7 March 2000, within the
required 15 sitting days.
1.3
All reporting requirements are
met. This is the first annual report of the Australian Radiation Protection and
Nuclear Safety Agency (ARPANSA) which was created out of the merging of two
organisations - the Australian Radiation Laboratory (ARL) and the Nuclear
Safety Bureau (NSB). The annual report of ARPANSA covers the period 5 February
to 30 June
1999. The report also includes the last
annual report on the operations of the NSB, for the period 1 July 1998 to 4
February 1999. The powers and functions of
the Director of the NSB were transferred to the Chief Executive Officer (CEO)
of ARPANSA during the transition period
- 6 months from the beginning of the day when the Australian Radiation Protection and Nuclear Safety Act 1998 (ARPANS
Act) commenced.
1.4
The statutory office of the CEO
of ARPANSA and ARPANSA itself were established on 5 February 1999 by section 14 of the ARPANS
Act. Section 60 of the ARPANS Act
sets out the quarterly reporting requirements of the CEO of ARPANSA to the
Minister for Health and Aged Care in respect of the operations of the Agency
(pp.3-4). Quarterly reports were tabled in the Senate on 26 June 1999, 28
September 1999, 9 May 2000 and 27 June 2000 in accordance
with this statutory requirement.
1.5
The ARPANS legislation provides
a licensing framework for the regulation of radiation sources and nuclear and
other facilities controlled or operated by Commonwealth agencies and sets out
the functions of the CEO of ARPANSA. The functions of the CEO are to promote
uniformity of radiation protection and nuclear safety policy and practices
across Commonwealth and State jurisdictions; to provide advice on radiation
protection, nuclear safety and related issues; to undertake research in
relation to radiation protection and nuclear safety; and to provide services
relating to radiation protection, nuclear safety and medical exposure to
radiation (pp.3-4).
1.6
The report provides a concise
overview of the Agency’s functions and activities. The report includes a
corporate overview, a report on performance against the functions of ARPANSA,
an account of some of the achievements of the Agency and appendixes containing
statistical and financial information on the performance and administration of
ARPANSA. The report states that the central priorities of ARPANSA during the
reporting period have been to make organisational arrangements for the new
Agency; establish procedures for regulation of radiation sources and nuclear facilities
controlled by Commonwealth agencies; and maintain the scientific, regulatory
and advisory services provided by the former ARL and the former NSB (p.9).
1.7
In relation to performance
reporting, the report notes a number of activities undertaken by the Agency.
These include promoting the development of uniform regulatory frameworks;
participation in the preparation of national standards, codes of practice and
guidance documents for radiation safety; and various research projects
(pp.15-19). In relation to the safety of the HIFAR research reactor the report
notes that there was a decrease in the total number of safety-significant
abnormal occurrences reported compared to the previous year and the number of
these occurrences remained low (p.26).
1.8
The Committee believes that performance
reporting by the Agency could be enhanced if future reports contained more
information about difficulties in meeting objectives in addition to
concentrating on activities undertaken and achievements. The Committee does,
however, recognise that as this is the first report of the Agency many of its
activities have only been recently initiated or activities are in their
planning stages.
1.9
In relation to consultancy
services, while the report contains some information on these services
including expenditures, more information on the purpose of the consultancies
should be included in future reports (p.113).
National
Health and Medical Research Council 1999
1.10
The report was tabled in both
houses of Parliament on 27 June 2000, within the required
15 sitting days.
1.11
All reporting requirements are
met. The report provides a useful overview of the functions and operations of
the National Health and Medical Research Council (NHMRC). The Council’s
performance is reported in chapters dealing with its four Principal Committees,
namely the Research Committee (Public Health and Medical), Strategic Research
Development Committee, Health Advisory Committee and Health Ethics Committee.
Each of these chapters contains information on the NHMRC’s activities, followed
by several profiles illustrating the particular Committee’s work. The
appendixes to the report provide statutory reporting information, including
details of the composition and functions of the Council and its Committees and
financial and human resource arrangements.
1.12
A separate volume, Grants Book 2000, details the health and
medical research grants recommended for funding in 2000 by the NHMRC.
1.13
The annual report notes that
the strategic directions adopted by the NHMRC in 1999 ‘combined the pursuit of
research across all areas of health and the development of a strategic research
capability that targets emerging health problems as well as areas where
research effort is underdeveloped’ (p.7).
1.14
Regarding performance
reporting, the report highlights a number of initiatives undertaken over the
reporting period. The report notes, for example, that the Research Committee
has been working towards reshaping its funding programs and peer review
mechanisms - ‘providing for a fairer, more contemporary and integrated approach
to research funding’ (p.5). The report states that these changes are consistent
with the findings of the Health and Medical Research Strategic Review and ‘will
ensure that the more than two-fold increase in research funding announced in
the last Federal Budget will be put to the very best use’ (p.5).
1.15 The Committee notes that as well as
recording achievements, the report also discusses several challenges facing the
Council and areas where improvements in performance need to be addressed. These
include an acknowledgment that implementing the recommendations of the
Strategic Review ‘will be onerous and resource intensive’ (p.6). The report
also notes that the joint programs with industry require more development; the
priority driven research program requires more expansion in partnership with
the States; the strategic approaches to research funding in the areas of rural
health research and Aboriginal health research need to be implemented; and that
communication strategies, such as use of the Internet, forums and consultation
visits need to be ‘further developed’ (p.6).
1.16 The report also states that that
restructuring of the Office of the NHMRC with the appointment of a Chief
Executive Officer ‘must be accomplished successfully, and the Office adequately
resourced’ to allow the NHMRC to fulfil its functions (p.6).
Concluding comments
1.17
The Committee’s examination of
the annual reports of the Australian Radiation Protection and Nuclear Safety
Agency and the National Health and Medical Research Council has shown that the
reports meet the required reporting requirements. The Committee considers that
the reports are of a high standard and provide a comprehensive overview of the
functions and activities of the statutory bodies under review.
Senator Sue Knowles
Chairman
September 2000